Navina, an Israel-based startup developer of an AI-powered clinical platform for primary care, secured $15 million in Series A.
The round was led by Vertex Ventures Israel, with Schusterman Family Investments (SFI) and existing investor Grove Ventures also joined the round.
This brings the company’s total funding to date to $22 million, raised within 12 months after commercial launch.
The additional funding will allow Navina to accelerate investment in its AI technology, and expand within physician groups and the enterprise healthcare market.
Company: Navina technologies
Round: Series A
Funding Month: October 2021
Lead Investors: Vertex Ventures Israel
Additional Investors: Schusterman Family Investments (SFI) and Grove Ventures
Company Website: https://www.navina.ai/
Software Category: AI-powered clinical platform
About the Company: Navina created the first AI-based model that understands the complex language of primary care patient data. The platform provides clinicians with precise data as well as offering recommendations. Navina's AI-based insights bring potentially missed diagnoses to the attention of physicians, highlighting opportunities for better, more preventive patient care. The company has been invited by the American Academy of Family Physicians to be part of its Innovation Lab. Navina has also proven itself to increase practice revenue. Groups that have adopted the platform are seeing significant increases in HCC-RAF (Risk Adjustment Factor) scores, which translates into millions of dollars in revenue.